Desensitization in Kidney Allograft Using Daratumumab

Clinical trial NCT04204980 · COMPLETED

Trial details

NCT number: NCT04204980
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Allosensitization Kidney Transplant Rejection Antibody-mediated Rejection

Start date: 2020-02-18
Primary completion: 2023-06-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.